Fmoc-L-Dab(ivDde)-OH

Fmoc-L-Dab(ivDde)-OH is an Fmoc-protected L-2,4-diaminobutyric acid derivative bearing an ivDde-protected side-chain amine, where the stereogenic center at the α-carbon is fixed as L. The molecule contains an aromatic fluorenylmethoxycarbonyl (Fmoc) group for N-terminus protection, a carboxylic acid handle for C-terminal peptide coupling, and an acid-labile ivDde protecting group that masks the side-chain primary amine during chain assembly. The presence of orthogonal protecting groups enables sequential deprotection and controlled functionalization of the side-chain nitrogen without disturbing the backbone coupling site. The resulting chiral amino acid building block participates in standard peptide synthesis chemistry and can be converted into side-chain-modified derivatives for downstream scaffold elaboration and biochemical labeling workflows.

1. Peptide Synthesis

Fmoc-L-Dab(ivDde)-OH serves as a protected amino acid building block for solid-phase peptide synthesis and related peptide coupling workflows where controlled access to both backbone and side-chain nitrogens is required. The Fmoc group supports iterative N-terminal deprotection and re-coupling, while the ivDde-protected side-chain amine remains masked to prevent side reactions during peptide chain elongation. The free carboxylic acid enables amide bond formation using standard peptide coupling strategies, yielding peptides with a defined L-configuration at the Dab α-carbon. Stepwise orthogonal deprotection can then expose the side-chain amine for subsequent branching, crosslinking, or conjugation, supporting peptide analog construction and peptide library generation.

2. Side-Chain Functionalization

Fmoc-L-Dab(ivDde)-OH is suitable for chemical biology and synthetic organic chemistry applications that require late-stage installation of functional groups at the Dab side-chain amine. The ivDde protecting group is designed for orthogonal removal relative to Fmoc, allowing selective unmasking of the side-chain nitrogen after peptide assembly or after intermediate formation. The exposed primary amine can undergo nucleophilic acylation, reductive amination, sulfonylation, or carbamate formation to generate amide, urea, sulfonamide, or protected amine derivatives while preserving the stereochemical integrity of the amino acid center. Downstream products include functionalized peptide conjugates, linker-bearing intermediates, and reactive handles for further derivatization in scaffold optimization and biomolecule modification.

3. Bioconjugation Chemistry

Fmoc-L-Dab(ivDde)-OH enables bioconjugation workflows where an amino acid-derived side-chain amine provides a controlled attachment point for biomolecule labeling. The compound's protected amine architecture supports compatibility with peptide-based targeting motifs, allowing incorporation of Dab units into peptide carriers before orthogonal deprotection triggers side-chain functionalization. The resulting amine-bearing peptides can be coupled to electrophilic partners such as activated esters, isothiocyanates, aldehydes, or haloacetamides to form stable amide or substituted amine linkages under conditions that do not require disruption of the peptide backbone. This amino acid derivative thus functions as a stereodefined intermediate for constructing conjugation-ready molecular constructs used in chemical biology research and applied labeling strategies.

4. Drug Discovery Scaffolds

Fmoc-L-Dab(ivDde)-OH supports medicinal chemistry-oriented synthesis of peptidomimetic and structure-activity relationship (SAR) scaffolds that incorporate a stereodefined diaminoalkyl motif. The Dab residue contributes a spatially distinct side-chain amine that can be converted into cationic, hydrogen-bonding, or amide-linked functionalities, enabling systematic exploration of binding interactions and physicochemical tuning. Orthogonal protection via Fmoc and ivDde can be leveraged to control when the side-chain becomes reactive, supporting parallel synthesis of analog series with consistent stereochemistry and functional group placement. The compound thereby serves as a chiral intermediate for generating peptide-like frameworks and derivatized analogs used in SAR studies and fragment-to-lead optimization chemistry.

5. Pharmaceutical Manufacturing

Fmoc-L-Dab(ivDde)-OH is applicable to process chemistry and pharmaceutical manufacturing contexts that require robust, reproducible peptide building blocks with orthogonally protected functional groups. The Fmoc-protected N-terminus and ivDde-protected side-chain amine provide a protection strategy that can be integrated into scalable peptide assembly routes, minimizing undesired side reactions during repeated coupling cycles. The presence of a carboxylic acid enables standard activation and coupling chemistry to form peptide bonds, while the orthogonal deprotection logic supports downstream intermediate generation for controlled functionalization steps. The compound can therefore be employed as a defined stereochemical input for manufacturing-grade peptide intermediates, linker-bearing intermediates, and protected amino acid derivatives used in fine chemical production pipelines.

1. Cationic cell-penetrating peptides are potent furin inhibitors

2. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

3. Tachykinin-related peptides modulate immune-gene expression in the mealworm beetle Tenebrio molitor L

4. TMEM16F and dynamins control expansive plasma membrane reservoirs

5. Multifunctional peptide-oligonucleotide conjugate promoted sensitive electrochemical biosensing of cardiac troponin I